| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |